This site is intended for Healthcare Professionals only.

Pharmacy Collect service to end from April 1

Date:

Share post:

The Pharmacy Collect service, which allowed people to collect rapid Covid-19 tests to do at home, would end from April 1, 2022 as part of rollback of domestic restrictions, the Pharmaceutical Services Negotiating Committee said.

This follows the prime minister Boris Johnson’s announcement earlier this week regarding the rollback of coronavirus related restrictions in England and subsequent publication of the government policy document – Covid-19 Response: Living with Covid-19.

The PSNC is working with the UK Health Security Agency (UKHSA) and NHS England and NHS Improvement to finalise plans for the end of the service.

Meanwhile, UKHSA has confirmed having ample stock levels of test kits, and to ensure an even distribution of lateral flow tests across the country, it is planning future deliveries across all test distribution channels.

Alliance Healthcare would receive last delivery of tests from the UKHSA warehouse on March 18, 2022, and pharmacies will be able to order for a short period of time thereafter.

UKSHA has also advised that further orders for kits should be based on current need and demand from people.

The negotiator stated that more information about the end of the service and final payment claims will be conveyed to contractors once details are finalised.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

ABPI: Increased pharma exports could boost GDP by £16.3 billion

ABPI urges political leaders to enhance healthcare and economic growth through strategic partnership The Association of the British Pharmaceutical...

The Importance Of Expanding Access To Dental Care For Rural And Undeserved Populations

In many rural areas and underserved neighborhoods, a critical issue is quietly emerging. Although often overlooked, its effects...

BGMA: More than 50% of UK generics face shortages without licensed alternatives

Brexit blamed by BGMA CE, Mark Samuels, as UK faces critical shortages in generic drug supply A recent report...

Paul Burden elected BGMA Vice-Chair, bringing 25 years of industry leadership

Veteran of off-patent sector to drive strategic engagement and patient access initiatives at BGMA The British Generic Manufacturers Association...